Patent details

EP3110440 Title: ANTI-CD38 ANTIBODIES FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

Basic Information

Publication number:
EP3110440
PCT Application Number:
US2015017425
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157559394
PCT Publication Number:
WO2015130732
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CD38 ANTIBODIES FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
French Title of Invention:
ANTICORPS ANTI-CD38 POUR LE TRAITEMENT DE LA LEUCÉMIE LYMPHOBLASTIQUE AIGUË
German Title of Invention:
ANTI-CD38-ANTIKÖRPER ZUR BEHANDLUNG VON AKUTER LYMPHOBLASTISCHER LEUKÄMIE
SPC Number:

Dates

Filing date:
25/02/2015
Grant date:
23/08/2023
EP Publication Date:
04/01/2017
PCT Publication Date:
03/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/08/2023
EP B1 Publication Date:
23/08/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/08/2023
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/08/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
DOSHI, Parul
Address:
United States (US)

Priority

1

Priority Number:
201461946008 P
Priority Date:
28/02/2014
Priority Country:
United States (US)

2

Priority Number:
201462004540 P
Priority Date:
29/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 35/02; A61P 43/00; A61K 39/00; A61K 31/475;

Publication

European Patent Bulletin

1

Issue number:
202334
Publication date:
23/08/2023
Description:
Grant (B1)

2

Issue number:
202339
Publication date:
27/09/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202404
Publication date:
24/01/2024
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/02/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
31/08/2023 Power Of Attorney 1
04/09/2023 Outgoing Correspondence 1
24/08/2023 Power Of Attorney 1